MIP PHARMA DANMARK ApS
CVR 32886280 · Private limited company (ApS) · Active · Medium risk
MIP PHARMA DANMARK ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 16 annual reports have been published. The latest annual report (30 Jun 2026) shows equity of DKK -690k and a net result of DKK 27k. CEO: Jochen Steinhage.
Bankruptcy risk for MIP PHARMA DANMARK ApS
1.1 × the average (1.41%) · higher risk than 79% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32886280
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (16 years)
- Address
- c/o LEAD Advokatpartnerselskab, Store Kongensgade 40H, 2.
1264 København K - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 11k
- Auditor
- Rödl & Partner Danmark
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 16 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -2,498.3% |
| Current ratio | 91% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 8 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 130 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2026 | 2025 |
|---|---|---|
| Gross profit | DKK 58k | DKK -129k |
| Net profit | DKK 27k | DKK -156k |
| Equity | DKK -690k | DKK -717k |
| Total assets | DKK 28k | DKK 31k |
| Cash | DKK 15k | – |
| Short-term debt | DKK 30k | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Rödl & Partner Danmark.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2025 – 30 Jun 2026 | 92 | ||
| 1 Jul 2024 – 30 Jun 2025 | 150 | ||
| 1 Jul 2023 – 30 Jun 2024 | 19 | ||
| 1 Jul 2022 – 30 Jun 2023 | 170 | ||
| 1 Jul 2021 – 30 Jun 2022 | 97 | ||
| 1 Jul 2020 – 30 Jun 2021 | 100 | ||
| 1 Jul 2019 – 30 Jun 2020 | 113 | ||
| 1 Jul 2018 – 30 Jun 2019 | 100 | ||
| 1 Jul 2017 – 30 Jun 2018 | 108 | ||
| 1 Jul 2016 – 30 Jun 2017 | 104 | ||
| 1 Jul 2015 – 30 Jun 2016 | 138 | ||
| 1 Jul 2014 – 30 Jun 2015 | 146 | ||
| 1 Jul 2013 – 30 Jun 2014 | 106 | ||
| 1 Jul 2012 – 30 Jun 2013 | 94 | ||
| 1 Jul 2011 – 30 Jun 2012 | 180 | ||
| 29 Apr 2010 – 30 Jun 2011 | 145 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jochen Steinhage | Current | |
| CEO | Peter Denk | ||
| CEO | Ursula Seidel | ||
| CEO | Martin Osterhues | ||
| CEO | Peter Johannes Lenbet | ||
| Owner (100%) | MIP Pharma GmbH | Current | |
| Founder | Nils Kjellegaard Jensen | Current |
Address history (3 moves)
| c/o LEAD Advokatpartnerselskab, Store Kongensgade 40H, 2., 1264 København K | |
| c/o LEAD Advokatpartnerselskab, Store Kongensgade 40H, 2., 1264 København K | |
| c/o LEAD Advokatpartnerselskab, Frederiksholms Kanal 20, st., 1220 København K | |
| c/o Advokatfirmaet Kjellegaard Jensen, Tuborg Boulevard 12, 3., 2900 Hellerup |
Other companies at the same address
- A Star Fashion Trading ApS Bankrupt
- BBA RÅDGIVNING ApS Bankrupt
- BG SOLUTIONS A/S Bankrupt
- DRIFTSSELSKABET AF 30/1 2004 A/S Bankrupt
- Daneurotech ApS Bankrupt
- EJENDOMSSELSKABET KAROLINEVEJ 12 ApS Bankrupt
- ENGEL HENRIKSEN INVEST ApS Bankrupt
- FANCY PANTY København ApS Bankrupt
- GRØNNBÆK DESIGN & ACCESSORIES A/S Bankrupt
- IT SERVICE, ST. KONGENSGADE A/S Bankrupt
- K-Power Denmark ApS Bankrupt
- LIMACASA SERVICE ApS Bankrupt
- LP af 1. oktober 2023 ApS Bankrupt
- MUT ApS Bankrupt
- Mimos & Cotton Organic ApS Bankrupt
- NIKOTRADE ApS Bankrupt
- NILAKANTAN HOLDING A/S Bankrupt
- OPQ 1 ApS Bankrupt
- PSR Group ApS Bankrupt
- Portillo Denmark ApS Bankrupt
- REMIC MICROPHONES ApS Bankrupt
- RETAIL CONCEPT ONE ApS Bankrupt
- THORA A/S Bankrupt
- WENZEL. ARKITEKT APS Bankrupt
- 12Build ApS Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about MIP PHARMA DANMARK ApS
Has MIP PHARMA DANMARK ApS gone bankrupt?
No, MIP PHARMA DANMARK ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MIP PHARMA DANMARK ApS?
Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.
Who is the CEO of MIP PHARMA DANMARK ApS?
Jochen Steinhage is the CEO of MIP PHARMA DANMARK ApS.
Who is the auditor of MIP PHARMA DANMARK ApS?
MIP PHARMA DANMARK ApS most recently used Rödl & Partner Danmark.
When was MIP PHARMA DANMARK ApS founded?
MIP PHARMA DANMARK ApS was founded on 29 April 2010.
What is the equity of MIP PHARMA DANMARK ApS?
Equity was DKK -690k according to the annual report for the period ending 30 June 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.